干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
中源协和

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 41985|回复: 0
go

干细胞移植常用生物学词汇 [复制链接]

Rank: 1

积分
威望
3  
包包
20  
楼主
发表于 2008-12-27 14:20 |只看该作者 |倒序浏览 |打印
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸
0 V6 X* n/ h0 d9 t3 S2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷
8 I" n% I; `8 U) R7 x# ~3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷; M! F0 h6 V. G8 x: \
5-Aza:5-azacytidine,5-氮(杂)胞苷
9 q5 _- V0 |' c# M+ ~a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物' y+ H3 ?! D6 B9 a3 b1 ~4 ?
AA:aplastic anemia,再生障碍性贫血% s8 C+ }& R3 _! G  K+ V  M- M
AAV:adeno-associated virus,腺病毒相关病毒5 _- X8 g' u$ d
Ab:antibody,抗体
3 w, _* b% f+ q- ^+ v+ AABC:avidin-biiotin complex method, 亲和素生物素复合物法
4 V- [& A* P+ C. m! lABMT:autologous bone marrow transplant,自体骨髓移植
5 X! {9 n; \9 E: d, Z6 YAc:accessory cell,辅佐细胞
; o4 `. y: W  MACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖' j$ j9 x0 N* n) b. W
ACP:acid phosphatase,酸性磷酸梅* M' L; `; Z5 b1 `9 N5 W
ACTD:actinomycin D,放线菌素D
0 M% a' s  I( w' `6 o6 g* QAcute:急性的
* t; p" x" \2 ~; O' MACV:cyclovir,阿昔洛韦! x8 V. t( w5 v% L+ [
Ad:adenovirus,腺病毒
5 X, g: V1 V4 m" p+ f6 a5 Z7 {AD:antigen determinant,抗原决定簇
1 I1 G9 A5 n) V6 EADA:adenosine deaminase,腺苷脱氨酶
% p- N  n2 D, x) m, v+ DADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性
3 _. F$ B% l. HAdjuvant therapy:辅助治疗
2 E' ^* U  \1 R% n/ E' KAEL:acute erythrocytic leukemia,急性红白血病2 V1 r/ j1 p! {( E* z( E4 C- T! `
AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病
3 U3 s& d# m0 TAFP:alpha fetoprotein,甲胎蛋白
3 d9 Z$ l1 ]: {7 AAg:antigen,抗原( }" t" l# l/ T5 @8 h# n: W
aGVHD:acute graft versus host disease,急性移植物抗宿主病+ ]  `9 M- Z$ K, t7 S% g1 _
Aid:anti-idiotype antibody,抗独特型抗体" v5 j) O* t# Q
AidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征
9 w5 ?1 \/ V# PAIF:apoptosis-inducing factor,凋亡诱导因子
# M- z7 b# c* ~/ ]! y& Y4 GAIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血; g# c! \8 c' \& q1 p
AL:acute leukemia, 急性白血病
: k1 w2 H! x$ X, OALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
6 J3 T8 ^% N/ P) T6 V; PALG:antilymphocyte globulin, 抗淋巴细胞球蛋白
  Z! l; ?, F$ j& rALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位
. J9 `, d  K: j3 C( hALL:acute lymphocytic leukemia,急性淋巴细胞白血病& G9 m# g: L# \
Allo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植
' |* q! F* q. l! qAllo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
' j% V! Y5 _' ?Allogeneic:异基因的 1 n0 R" P9 U2 d' m& `
Allograft:异体移植物 / j% K$ z! b& B
Alopecia:脱发
' g9 O3 \4 N" m: \) C' g; qALP(AKP):Alkaline phosphatase,碱性磷酸酶
" _- x3 Y7 }& k* w! QAM:adhesion molecule,粘附分子: M4 m2 g  ]/ w8 e! L
AMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病! E1 t, q5 e: |' J+ S! s% J) D
AML:acute myeloid leukemia,急性髓性白血病
2 L! H; Z! x0 uAMM:agnogenic myeloid metaplasia,特发性髓外化生
0 O, u  B4 N* |& HANA:antinuclear antibody,抗核抗体 6 [* t! N& p( ~4 V" L+ n
Ana-LL:anaplastic large cell lymphoma,大细胞淋巴瘤
) a9 y1 @; Z  u- ~$ k1 W5 eAnaphylaxis:过敏症& y! ~, P5 k) H1 k, f" e
$ e+ K- [. u) h$ S" S7 D& Y
ANC:absolute neutrophil count,中性粒细胞绝对值
4 t. [+ b% _% @* _$ ]* q$ p. u2 l. Y  UAnemia:贫血
% z7 `" s  M- W! s' e" d, s; OANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病
' A1 n8 n) y* P1 W/ ]Antibiotic:抗生素;抗生的 ( `) Y8 f1 l, E; ~% b! F
Antiemetic:止吐剂,止吐药 7 r: c! K1 M1 G7 {
antineoplastic drugs:抗肿瘤药物4 i% t  c2 q4 @$ K5 F7 e- g% c
Antisense:反义引物0 h! J1 b' W$ y" b+ C3 o# W
APBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植: E8 }9 D3 ~$ u6 f
APC:antigen processing cell,抗原呈递细胞4 S  }4 e% X4 @$ p1 ~
Apheresis:血浆分离置换法,血液成分部分清除
% T$ {" y; R) Q1 l. D- G* i5 PAPL:acute promyelocytic leukemia,急性早幼粒细胞白血病
" \, |( l9 Y, g2 }+ I; PAplasia:发育不良,成形不完全 # S2 g8 c- o: l2 p$ n5 v0 b
Apoptosis:凋亡. J: F, V/ c' @; p% G4 D
Ara-C:arabinosyl cytosine,aracytidine阿糖胞苷1 r8 _: i8 w9 ^# m5 G
ARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病
7 F( i/ q- W& C" ?( r  O6 O( nAscites:腹水
* Y% Z8 E( z, c; aASCT:autologous stem cell transplantation,自体干细胞移植0 S: r4 q; T$ f( f' W
Aspergillus:曲霉属
% M( j3 R4 f* b1 u7 m, fASS:anterior superior spine,髂前上棘: n1 V- F* C! m, }
AT1257:nitrocaphane,消瘤芥) |, n5 g, A3 C8 |
ATG:antithymocyte globulin,抗胸腺细胞球蛋白
2 |5 L  L4 F! u/ Z7 ?ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤  `, Q% b- G) [
ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征. ]& Z, t; A  r5 {( P
ATRA:all-transretinoic acid,全反式维甲酸8 r$ [( b  M( b# H: [, \/ I* H
AUL:acute undifferentiated cell leukemia,急性未分化细胞白血病- B( B) {$ W/ Q; f( B( e/ V1 w
AuSCT: autologous stem cell transplantation,自体造血干细胞移植9 p. A. [$ `1 h' M) z
Autologous:自体的 2 Z7 H1 t0 _8 s: `2 Y
Autograft:自体移植物 - J5 G5 j, u; d0 V6 z
Auto-BMT: autologous bone marrow transplantation,自体骨髓移植
$ {# j: {/ q0 b9 Z) [β2-MG:β2-microglobulin,β2-微球蛋白
+ B& e' j" k, k; O0 jBack-up:备份0 {3 Q4 w% o" ?, u- u4 Y' {
BCNU:Carmustine,卡氮芥,卡莫司汀
& Z: T- m7 S. W6 aBCR:breakpoint cluster region,断裂点丛集区
  m! N4 f8 T4 cBFU-E: burst-forming unit-erythroid,早期红系集落生成细胞
: v$ Y6 m3 A9 a$ R6 IBiopsy:活检
7 {& L+ a! J1 ~8 K, |8 K. v) nBlast cell:原始血细胞,母细胞 9 n, W7 x+ x0 N4 }) _7 B
Blast-CFC:blast colony forming cell,原始细胞集落形成细胞+ J+ |7 Y" [3 X8 `7 q
Blast crisis:原始细胞危象
4 h7 t' `' B/ P- g2 n# c/ w9 UBm:memory B lymphocyte,记忆B淋巴细胞5 M9 f+ P( b0 Q- k/ Q/ g; l
BMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病: H0 M" y6 n( Y( ^) a# l+ V( j
BMT:bone marrow transplantation,骨髓移植/ ~! C3 m3 b9 V/ s5 ~$ l
Bone marrow biopsy:骨髓活检9 V0 E' f$ q7 H* R9 R! c6 d6 V% S. a
Bone marrow puncture:骨髓穿刺  M  I: I- {* J- \% H
Bone marrow smear:骨髓穿刺涂片
  H# {. ?3 z3 \: `BRM:biological response modifier,生物应答调节剂
4 Z# N* U  I/ G8 BBu:busulfan,白消安,马利兰 ; a" O0 l. r- @1 e9 ~; U' [
Buffer:缓冲,缓冲剂,缓冲液
6 ^* V2 s, C7 u+ D! uCALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原. h6 m0 o/ b6 @, K
CAM:cell adhesion molecule,细胞粘附分子: N" L7 Q: }9 R* c; [$ ?7 V
Candida:念珠菌属,假丝酵母属
9 \4 @2 G. P: G6 k& LCatheter:导管
2 \' T5 X5 ?" TCB:cord blood,脐带血0 Y. p  U6 T3 X2 F
CB1348:chlorambucil:苯丁酸氮芥8 \( }5 O1 u7 R6 F+ J: l
CBC:complete blood count,全血细胞计数
8 k* _9 O3 r6 d+ a# i. RCBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤3 D. y$ [  ]! G7 k3 v) ^3 n9 B
CBSCT:cord blood stem cell transplantation,脐血干细胞移植
1 N: Z) Z; F9 I5 [1 z, n0 Z- ]3 tCCI:corrected count increment,校正增值计数
# f( h! e* H$ m( r( Q! V6 q/ JCCNSA:cell cycle non-specific agents,细胞周期非特异性药物 6 t7 q, a& J4 S5 m6 ]  Q+ x
CCNU:lomustine,洛莫司汀,环己亚硝脲
5 l6 u' x/ G3 R% cCCR:continuous complete remission,持续完全缓解* R# g1 H' C+ j) {# n
CCSA:cell cycle specific agents,细胞周期特异性药物0 I7 P0 A. s) y, Q# _4 T
CD:Castleman's disease,Castleman病7 b, ?+ z) }6 V# ~
CD:cluster of differentiation,分化群
+ e8 F0 r1 K+ o; HCD3AK:CD3 activated killer,CD3激活的杀伤细胞( u  x( I6 Q0 E# \5 O, e: E
CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶; S& {  l/ S" H/ Q# M+ i% d# K
CEA:carcinoembryonic antigen,癌胚抗原: W4 K& h8 n' x6 q2 s9 H( y
CEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
! k, @7 K  t" d. rCentral line:中心静脉导管,见central venous catheter. 9 [1 L' a8 Q  Q; H
Central venous catheter: 中心静脉导管,又叫做central line,Hickman catheter
! k, g& h4 `# H: F. PCentrifugation:离心
& Z  ~5 E$ u0 Z# O5 W4 rCFC:colony-forming cell,克隆形成细胞
. L  }8 r3 U: I  i( ?( `- wCFU:colony-forming unit,集落形成单位
$ P( a8 m0 g: f9 N/ I5 h& yCFU-Blast:colony-forming unit-Blast,原始集落生成细胞# E. f7 d' ]$ V; [2 M+ z2 s
CFU-E:colony-forming unit-erythroid,红系集落生成细胞
1 }" l) F6 ]$ Y; VCFU-G:colony-forming unit-granulocyte,粒系集落生成细胞! G8 D# _( M1 q. h
CFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞/ R  h( r/ I0 w7 m  |" D2 q& k
CFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位
. [' y8 g/ m9 y! i% E7 sCFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞8 }% ?3 U3 l$ x  |& e
CGD:chronic granulomatous disease,慢性肉芽肿病( Z$ x: s6 Z, ]+ }
CGP:circulating granulocyte pool,循环粒细胞池
! \& p! l- ]- y" KcGVHD:chronic graft versus host disease,慢性移植物抗宿主病: A: [* ?6 U% b1 R! y
Chemo-responsive:化疗敏感的 + l& H0 h0 A$ V/ e. J9 Y
Chemotherapy:化学疗法 " ]) \; F. x) n5 b( U
Chronic慢性的 4 |  w; @' F! ~/ u. Z
C.I.:continuous infusion,持续静脉点滴
, v4 p' R9 s' [3 j+ nCIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞2 _" A0 Z0 O( k
CliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统
7 q; j/ \% q" O& _0 U% C3 GCLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病
1 S8 C0 Y3 ]9 U: kCML:chronic myelogenous leukemia,慢性粒细胞白血病  w2 y, p, H$ ^
CML-AP:CML-accelerated phase,慢性粒细胞白血病加速期
% V* ^) ^8 x/ VCML-BP:CML-blastic phase,慢性粒细胞白血病急变期, ^( r* T0 ^! I- u) L% R8 T
CML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
/ w9 n9 D" N; S; i+ HCMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病  Z. y, V6 d' V/ k
CMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病
( q2 x6 E; r& V9 LCMV:cytomegalovirus,巨细胞病毒0 L/ q5 J5 ~. }" I6 d
CNR:cytokine negative response cell,细胞因子不反应细胞
/ D$ T1 K; [% d0 n7 ICNS:central nervous system,中枢神经系统
( e8 X' [* k2 I$ X8 `- ]* B( NCNSL:central nervous system leukemia,中枢神经系统白血病
- h# m# v$ u% B! x' \) d4 \Collection: 采集$ t+ D* h0 L6 c  g  @& i# p
Colony stimulating factor:集落刺激因子 - Q9 O8 e2 T# z& n! @; Y
c-onc:cellular oncogene,细胞癌基因- @8 H, ~8 ~8 A: t5 t  A
Conditioning:预处理 9 v3 m$ w0 N) O$ V
Conjunctivitis:结膜炎3 z& P0 d1 W2 b. Z6 T8 M3 N2 C
Convalescence:恢复,恢复期# L9 E) u$ X! C6 F- ^: N
CP:cancer procoagulant,癌性促凝物质
* s0 T6 u' N/ nCPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖! b7 R, g1 X9 r9 i& G+ |
CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤
, T; C& Z, O1 Z4 _# P+ H2 E5 V0 ACpmax:peak concentration,峰浓度( I5 V  o0 s% o2 h- B, n5 X* R  q
CPT:camptothecine,喜树碱6 V6 {( |0 n4 U+ L  p1 S
CR:complete remission,完全缓解
+ [( }9 y1 e) |) k$ Y0 xCRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白% U9 K- k; R) N
CRP:C reaction protein,丙反应蛋白
$ |. ^7 L0 x2 I/ l- [; iCRR:complete remission rate,完全缓解率
. j. r0 {8 y' e6 T+ Y( UCryopreservation:冷冻保存,深低温保藏
: f, a$ ^# e5 B0 K( SCSF:colony stimulating factor,集落刺激因子6 X- ]) G5 `4 {3 B" R
CSF:cerebrospinal fluid,脑脊液
; Z5 c6 F( K  r* i" k) |& L+ ICTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤
. j' S- {- C& ]' D; K$ E; vCTCL:central T cell lymphoma,中枢T细胞淋巴瘤
+ k# N0 P7 D- f* C% _CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞0 v0 Q" L2 }7 X+ N2 `7 ~  p
Cyclin:周期素/ S% A/ R, L/ f, J& @  b2 P  d
Cytomegalovirus:巨细胞病毒 / f7 `9 t5 C/ C4 P; S  J& o. n' L
DC:dendric cell,树突细胞
* z. a3 O! J/ u8 i3 ^! [+ j! SD-D:D dimer,D-二聚体
! M/ p4 ^. p3 C( s% h0 z6 ~Del:deletion,缺失
, n: J3 Z% C9 c. ^  l' s# e* F5 vDermatitis:皮炎
( m8 R. Z) F, K4 E& W" [* vDe nova AML:非继发性急性髓性白血病
6 Y. m3 ?# f4 o  p( |8 R& lDFS:disease free survival,无病生存期+ N. D. M" e/ f+ ~# x
DI:DNA index,DNA 指数4 j; k% ?% g6 h* j/ K7 T
DIC:disseminated intravascular coagulation,播散性血管内凝血- O. {  R# o; I0 B  `7 {
Dilution:稀释7 e& ~  q0 n( ^, P$ j
DL:discordant lymphoma,混杂型淋巴瘤
; G3 c" ^3 |; m% _3 X9 w$ f8 aDonor:供者/ \# ~. D$ l- A# W& x; D+ o
Dysplasia:发育不良,发育异常 * O- U- d; z# a- _: @( x
EBV:Epstein-Barr virus,EB病毒
1 e6 i) B0 r. uECM:extracellular matrix,细胞外基质6 g3 ~' h! e  M7 ]
-ectomy:(后缀)(外科)切除,除去,去掉
9 w( j! r/ a' P! I' X. I. `Edema:水肿
: Z- W7 X; l# E4 U) VEGF:epithelial growth factor,表皮生长因子1 P- V- Q; H" `2 }! X  v
-emia:(后缀)血液疾病
8 B& L7 S* R2 e, U. CEncephalopathy:脑病
$ f* G* q5 k# H  t) q2 iEncode: 编码, n: G0 P9 P) T
Engraftment:移植物植入 ( A+ \8 k, m& B7 [  N& d! H
Enrich:富集
+ ?6 I1 h7 j: h2 {1 b3 d: V  L0 @Enzyme:酶 + w  T' p# Z. k* D  C- f! N
Eosinophil:嗜酸性粒细胞# J7 V3 Q" e, T1 q: w" d
EPO:erythropoietin,促红素,红细胞生成素
' \& f+ f3 V8 i! K7 CETT:essential thrombocythemia,原发性血小板增多症6 o/ ?9 s$ L1 Y# c& L9 D
Ex vivo:体外 - y* n1 [0 x- C" Y0 f! U0 V2 v
FACS:fluorescence activated cell sorting,荧光活化细胞分选系统% a; N2 v( X; k$ \6 W0 j1 \
FCM:flow cytometry,流式细胞分析技术, `. W9 c) ]# v/ d8 j' F% R
FDC:follicular dendritic cells,滤泡树突状细胞
0 Z1 C5 R' Q; i9 Y; f, w' g+ xFDGF:fibroblast derived growth factor,成纤维细胞源生长因子 $ ~, d1 l+ H: r" Q, D* E
Febrile:发热的
1 {3 a! J" k6 aFFP:fresh frozen plasma,新鲜冰冻血浆
6 I; _8 @1 {+ L# d# r- y) aFGF:fibroblast growth factor,成纤维细胞生长因子; H0 P" T! O+ T. c% L7 S
FHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症  \$ h/ ]" t( S% u
FISH:fluorescence in situ hybridization,荧光原位杂交
& X3 E1 b4 @( C, W' tFMF:familial Mediteranean fever,家族性地中海热
1 V8 j- x! [: R. OFoley catheter:弗利氏导尿管,气囊导尿管 % h; A- X1 Z/ o% N. W8 z; @
FrTBI:fractional total body irradiation,分次全身照射' a$ N! m7 B2 m
FSRC: 胎羊体内增殖的人造血干细胞6 L+ p: X' T6 ]4 G
Fungus:真菌
! b+ m+ s" {) U% n* O8 b, I) \Fungi: Fungus复数形式
4 }: D$ S5 ]+ a$ |G6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶/ d$ K7 N% P+ u  F3 H9 f/ Z  x$ t
Gastritis:胃炎 0 E. v0 c% q) b4 O7 ^' d
Gastrointestinal:胃肠道的 8 h5 W  r, L) U& R7 s
G-CFC:granulocyte colony forming cells,粒细胞集落形成细胞. M# n' f+ y, f* |% [
G-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子 6 G# J* s. M! \5 I6 H
GCV:cytomegalovirus,巨细胞病毒9 t) m2 e6 p& V: k, P
GCV:ganciclovir,更昔洛韦
+ k4 S) @% F5 k$ Q6 e# P  EGI:gastrointestinal,胃肠道的
( w# @5 K1 ?7 c% N& N( o' b- U( X7 mGM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子
( a7 I! j4 s3 O& j% LGM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞  P9 l- m4 H! ~+ G( ]
Graft rejection:移植排斥(反应)
* Z6 t- {: {0 E0 DGraft-versus-host disease:移植物抗宿主病 ; j" s1 `+ {$ k0 a5 t
Granulocyte:粒细胞 3 l: n9 i) |' s9 j& i2 |$ d$ t2 d
Growth factor:生长因子
, g3 P- A" e4 X% s# d: o# N3 HGTR:granulocyte turnover rate,粒细胞转换率$ I' a' p8 W8 }+ j" v+ U+ J
GVHD:graft-versus-host disease,移植物抗宿主病
4 O. I- l: Q7 }3 }# `GVHR: graft-versus-host reaction,移植物抗宿主反应: b0 v" t4 v: K) @8 T) @2 R
GVL:graft-versus-leukemia,移植物抗白血病
0 [9 H. R$ q9 h) z1 BGVT:graft-versus-tumor,移植物抗肿瘤% U6 [* j( U; X; O  w5 @
Haploidentical: 半相和的" d3 k% Z, c" D! s
Harvest: 收集,采集
. @0 _& |1 `- x/ a& q" ]HC:hemorrhagic cystitis,出血性膀胱炎+ z% w, u: W/ Y% C' l1 y
HCL:hairy cell leukemia,毛细胞白血病! N, K9 C8 c- C5 N; v
HD:Hodgkin's disease,霍奇金病6 ^4 K( l% H3 g: a; ]% S
HD:high dose,大剂量
7 n, {* L- q! v9 ]  P( \Hematocrit:红细胞压积 - x( @* ?* y' Z0 W* j
Hematology:血液学 + K* z+ k! {3 ^- J5 d4 L9 d$ |
Hematopoiesis:造血作用,生血作用
% s2 J/ z  w8 N# {5 u6 P- n6 p1 Q" S. JHematopoietic system:造血系统# E4 T( q4 _3 `3 N# n* W! F+ H5 O. ~
Hemoglobin:血色素,血红蛋白 0 ?( F7 P# J- N6 L$ w5 ]
Hemorrhage:出血 1 A" S+ D/ P0 T: l
Hemorrhagic cystitis:出血性膀胱炎 / o0 O0 Q1 K& W+ s# r
Hepat - :(前缀)肝的( ^5 s2 G5 H9 E- I& H3 s8 K( b: u  @1 K- N
Hepatitis:肝炎 , q' m, \2 S, l. d
HES:hypereosinophilic syndrome,高嗜酸粒细胞综合征( w3 F7 W! ?* a4 f7 y* u. w; |$ k
HGF:hematopoietic growth factor,造血生长因子
( ^( S0 S; N. _8 C' f& jHHV:human herpus virus,人疱疹病毒6 l" ]* H7 ], ]4 v. B1 E/ L
Hickman catheter:Hichman导管,中心静脉插管
& M- {' d# p( M; ]7 IHIV:human immune deficiency virus,人免疫缺陷病毒
6 i7 J9 {2 _* h# `. _HLA:human leukocyte antigen,人类白细胞抗原
7 `, f$ E2 W7 Q: F$ l2 R& oHLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症
# O0 @8 d- ^# z2 @4 b3 JHMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症1 J; \- A+ ?5 \, X2 v. }2 }
Homogenic transplantation:同基因移植8 W+ o0 i& a+ m: b& w) m
Homozygote:纯合子( T1 M1 x6 v# \  O
HPC:hematopoietic progenitor cell,造血祖细胞
0 W6 x, [1 Q: O& h( p# cHPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位
% w# r. B: N4 V! H7 d- s4 eHR-ALL:high risk ALL,高危型急性淋巴细胞白血病, E8 L* ]; B3 \0 \+ v! S8 Q1 g
HSC:Hand-Schuller-Christian disease,韩-薛-柯病7 ^( x  o7 b- E  R; Y2 u6 |: C$ d
HSC:hematopoietic stem cell,造血干细胞  F/ O; ~2 ]( s
HSR:homogenously staining region,均染色区5 ?& r; l/ d  s2 K+ H$ \2 L
HSV:herpes simplex virus,单纯疱疹病毒
4 D+ |: ?& k: UHTC: typing cell,纯合子分型细胞
$ C8 `7 Q5 p/ x& _" {0 _! KHTLV:human T cell leukemia virus,人类T细胞白血病病毒+ r/ H5 F6 n6 B  }
HVOD:hepatic venous occlusive disease,肝静脉闭塞病
" ]$ ?1 |; ]7 }! w9 l* t* P) `Hyper- :(前缀)高,超,(过)多5 I4 S; T  O4 ?$ ]
Hyperalimentation:高营养支持,静脉高营养3 X0 K4 N$ }( S& j
Hyperpigmentation:色素沉着过度 7 {5 H- o8 C: @7 ^% p: R# q
Hypertension:高血压
4 S' g  o  T! D1 N; Q, o3 E  O4 PHypo- :(前缀)(过)低,少于; W) u% y) [* X7 `9 Y& f
Hypotension:低血压0 ^" W2 k: R5 n/ g# m, B( d
IAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征
2 o8 S; |0 Z  a0 K  e0 u+ uid:medium dose,中剂量
- `$ Q0 [: f7 K% v0 @id:initial dose,初始剂量
$ a1 f; N/ S( D; mIF:involved field,累及野
+ D' m3 f0 q5 C  Z2 c# l4 [2 hIFN:interferon,干扰素! J2 P/ [: ^- n3 n; A5 g
Ig:immunoglobulin,免疫球蛋白 0 v) u9 e' ^" C0 p) u" l( D1 v
IGFs: insulin-like growth factor,胰岛素样生长因子
- a3 [+ B1 Q- i1 n: E9 EIgH:immunoglobulin heavy chain,免疫球蛋白重链* V, U$ T4 V" C/ o
IL:interleukin,白细胞介素; V3 P. K1 y# S$ e, z
Iliac crest:髂嵴 ; x" S) O0 L% P! R1 x# s* P" m
I.M.:intramuscular,肌肉注射8 J# ]1 k8 p; ]3 X4 _' G
Immune system:免疫系统
7 p% L, \! h& |- HImmunocompromised:免疫受损的 6 ]4 P; |2 G  j4 @: B7 d
Immunoglobulin:免疫球蛋白
  ~9 x& y. U; R. dImmunological tolerance:免疫耐受
) b/ M0 p2 p2 H" FImmunosuppression:免疫抑制
$ R6 b$ O+ W2 m& W/ k) NIncubation:孵育
/ O' @0 ?; h% n/ S' S  A3 Rinformed-consent:知情同意" X* F  ^) M% w7 h
Intravenous:静脉内的
: ~, P; C$ X. _" P4 dinv: inversion,倒位0 N5 o& d3 v% C" O+ z
in vitro: 体外,离体; f! ^# ~$ {0 V3 p( M
in vivo: 体内
) e- |1 `+ a% CIP:interstitial pneumonia,间质性肺炎
$ g, d) E/ J6 v8 i/ y( \Isolation: 分离' T2 x6 J& i0 H$ P
I.T.:intrathecal injection,鞘内注射
: ^, r) K  T) c2 `5 [7 `-itis:(后缀)炎症
% B& h1 t* _8 j3 [9 dITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜
) D7 r8 H  a# R/ q6 {$ K2 pJaundice:黄疸
3 ^, l2 K& B( O0 b- fKPS:Karnofsky score, Karnofsky评分; C. B& ?6 V7 a( G8 i1 A
LAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)% D9 o5 B4 A3 Q: `+ Y
Laminar air flow unit:层流间
  X) s+ S3 D" }! L8 @( c4 O0 R1 i4 RLCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症
0 _; |$ K$ I$ VLD:lymphocyte depletion,淋巴细胞消减型6 P5 n9 F  X) K6 R& x: T8 j
LD:low dose,小剂量; k/ h' Q6 G% X' {) I- y
LDH:lactate dehydrogenase,乳酸脱氢酶& ~2 I' L) N9 t7 q6 _
Leukapheresis: 白细胞采集物0 |1 Y' j8 u& X. L
Leukemia:白血病
4 F! [" l/ K1 ^, R2 X0 YLeukocyte:白细胞
) M$ K; o0 U  d  B/ U* f/ qLeukopenia: 白细胞减少症
+ v: \# \8 [; N* |5 D8 eLFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原
4 {  i, G1 a. u: b5 B& V) V3 ~3 u5 MLFS:leukemia free survival,无白血病存活期
  K/ a' Z1 s% K7 u6 q  y9 R+ G# }4 ]LGL:low grade lymphoma,低度恶性淋巴瘤
0 D" v  G; k. JLHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体
3 b  k$ r( N' Z( t3 FLI:labeling index,标记指数: k4 m* X$ |% K( C7 h$ O# _
LIF:leukemia inhibition factor,白血病抑制因子0 @' s" h5 f! z! `5 x6 |* t/ \6 l
Lineage:系
- V$ f1 x% }8 c  I% J# E) vLOH:loss of heterozygosity,杂合性丢失
6 S3 z4 o( A$ V0 MLP:lymphocyte predominance,淋巴细胞为主型
9 o7 }% U9 d& u8 r4 @# u' Z0 NLRP:lung resistance related protein,肺抗性相关蛋白1 U: i" |" ~9 @' X  {7 K2 v
LTB:life-threatening bleeding,致命性出血; @& O3 ~8 W7 {9 s0 r# n
LTC-IC:long-term culture-initiating cell,长期培养起始细胞' O3 K% f; O- H3 R2 L6 _3 o" d: M
LTR:long terminal repeat:长末端重复序列8 Y4 L" K3 \/ v; a: o4 _$ K% N
LVL:large volume leukapheresis,大容量白细胞单采0 |' n& X! {3 b" }
Lymphocyte: 淋巴细胞$ h5 M4 P9 a8 ~; y! d
Macrophage:巨噬细胞  r9 F% i) Z" E
MACS:magnetic activated cell sorting,磁性活化细胞分选3 q6 X/ R6 b/ p# o( I. a9 K2 Y
MAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)  m. \, d* d+ Q" V* `" N8 p4 w
Malabsorption:吸收障碍# [. h. H& w1 u& Z0 e# s
MALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷" [/ X9 i, G3 S. X. F
Matching:配型9 Z1 A9 Z+ P1 j" g1 U
MBDI:marrow blast decline index骨髓原始细胞减少指数
# o8 @" I2 }. R) G0 hMC:mixed cellularity,混合细胞型! X4 w) [# g- c( V3 p2 P
McAb:monoclonal antibody,单克隆抗体
  ?/ r3 @) z1 O2 G4 v, `mCR: median complete remission,中位完全缓解
* @, y+ X# S2 `: f0 Z1 N' W6 fMDR:multiple drug resistance,多药耐药
& _' {/ C. y- o* qMDS:myelodysplastic syndrome,骨髓增生异常综合征1 A( x* m$ _) ?7 \1 ]
Megakaryocyte:巨核细胞( k1 L$ b, ]* j( O: V
Metabolite:代谢物
1 {+ u, ]/ C& uMetastatic:转移的 / o1 P; Z3 x; {5 v: V
MF:myelofibrosis,骨髓纤维化
2 d6 ?: w6 G% R6 N; hMF:mycosis fungoides,蕈样霉菌病
2 E2 D: B1 P& o% u2 PMGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子) h0 t) F0 {) m: Q8 V) z1 _1 [
MGP:marginal granulocyte pool,边缘粒细胞池
/ q- S3 s9 y6 j4 ]7 ~/ H, ~MGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症8 a8 }% \/ y5 [7 o$ h
MH:malignant histocytosis,恶性组织细胞增生症
: c: B  x  |- }' hMHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统. _1 l3 P' _3 V
MHC:major histocompatibility complex,主要组织相容性抗原复合体$ l9 E# Y( f2 w5 l
MLC:mixed lymphocyte culture,混合淋巴细胞培养
. d, W1 B9 x) fMLL:mixed lineage leukemia,混合系白血病+ \! Q" ]8 G6 L7 [: Y. z! u
MM:multiple myeloma,多发性骨髓瘤
5 [" U; d0 [! w. E# C! r( bMNC:mononuclear cells,单个核细胞- P; Q7 T3 s! t4 Q2 k# f% B- B
Mobilization:动员, m' Y# o1 I4 w4 O# ?+ e: t* l
Monoclonal antibody:单克隆抗体 / K0 I$ ~4 A* }: B
Monocyte:单核细胞
6 e/ a, Y& F( R. D& P* }6 Q4 @$ x& l) LMonozygotic:单合子的/ e  ~: ~: Y! @7 @7 }2 q% M
Morbidity:发病率
$ {" P- ?- f! a2 I% i1 l. p; e; H( dMPD:myeloproliferative disease, 骨髓增殖性疾病. H9 R$ m3 `5 k' L2 S2 F9 q
MPO:myeloperoxidase,髓过氧化物酶
5 w; Y, g) |% O( i) HMRD:minimal residual disease,微小残留病变 6 e/ z( N- Y6 q4 ]% a3 p( w
MRP:multidrug resistance-associated protein,多药耐药相关蛋白8 q  W/ u1 X6 e, ?. R3 h+ `
Mucositis:粘膜炎 ( |$ K; t1 u- _
MUD:matched unrelated donor,非血缘关系配型相合供体
) s# d* V: Z* V% N) o  a# VNAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶
5 D: v% L. N- qNB:neuroblastoma,神经母细胞瘤1 Z5 o0 S* g$ K+ S) Z, i
NBM:normal bone marrow,正常骨髓/ Z9 _" k8 W4 Y# i) c  N
Negative selection:阴性选择
4 D6 e- G+ }7 W. B: B" cNeuro- :(前缀)神经的
% Q6 h7 r" w5 g" ]4 L- INeutropenia:中性粒细胞减少症
2 c1 f8 @$ q( j- B: }/ fNeutrophil:中性粒细胞
/ M5 Z# G' {+ k5 j5 VNG:neutrophil granulocyte,中性粒细胞
7 Q1 ~9 o) M' m: vNGF:nerve growth factor, 神经生长因子
1 `( W; u" {( [: e2 A  `' I' sNHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤
. j0 _5 N: g. n+ ^& MNK: nature killer cell,自然杀伤细胞
& d( j; n$ C5 z. F) oNonmyeloablative transplantation: 非清髓性移植9 ?5 N$ L9 q# z3 G. `0 |2 g. a( p! I6 X
NPO:不能进食
, W3 f- @) O( S; z1 \* WNS:nodular sclerosis,结节硬化型
3 P. N( M4 E# c7 c3 K& ^. sOncology:肿瘤学 ' C) i+ C2 p. n! ]8 p4 j
Oto- :(前缀)耳的
/ [) z- |5 `+ f! I+ XPA:plasminogen activator,纤溶酶原激活物
8 ]% l+ ]* Z" [8 E6 C* Z: GPacked red blood cells: 压积红细胞 0 C" f7 I9 h; }" k1 s6 K
PAE:post antibiotic effects,抗生素后续作用
( s7 J6 h+ b: S# q0 q; Y. mPAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂
6 z7 {1 M4 Q5 c' dPalliative:减轻的,缓解的
0 J) R# V8 w- t! q/ `* d1 fpalliative care unit (PCU):终末期病房,临终关怀病房. A+ i) h) I/ Z  `, z, }
Pancytopenia:全血细胞减少症
  G1 @! r' M% g-pathy:(后缀)病 8 s% H5 e- Z6 m3 I+ Y& M
PB:peripheral blood, 外周血4 \6 v" X! f+ B; G) b# y6 ?( @, Q
PBL:peripheral blood lymphocyte,外周血淋巴细胞
5 U- z) `" x% |- B) S1 IPBPC:peripheral blood progenitor cell,外周血祖细胞6 [. C# e+ f/ o6 L8 t: W3 R
PBSCT:peripheral blood stem cell transplantation,外周血干细胞移植: B6 G" o' G+ {' ?! z* F: q
PCA:procoagulant activity,促凝活性物质
. Q9 }* j" c( x8 xPCD:programmed cell death,细胞程序化死亡
7 n+ Q4 x7 e  S- ^( n$ U* HPCL:plasma cell leukemia,浆细胞白血病7 V& n* b8 M- T* A$ }
PCLI:plasma cell label index,浆细胞标记指数
7 ?4 g7 q( u: b+ l0 J, s( YPCR:polymerase chain reaction, 多聚酶链反应
+ u5 S9 a6 {7 J" q0 ^PCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析. O( ]! C0 y& i. l2 d0 w
PCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交6 B; N2 O% j# b: R# I+ r  p
PDD:percentage depth dosage,百分深度剂量8 U5 J3 @3 Q1 w7 h- X; C2 w9 j
PDGF:platelet derived growth factor,血小板衍生生长因子+ |0 T/ k4 }" L1 n! s+ j2 e' ^
PDR:primary drug resistance,原药耐药
$ u9 D3 R  ^9 t" P/ h" N2 I! I' _( RPE:plasma exchange,血浆置换2 g3 A. G& I+ J+ A+ C0 @
-penia:(后缀)缺乏,不足
6 x3 v3 M, T9 H4 c$ q- w5 L$ F+ UPeripheral neuropathy:周围神经病变
: D0 G- @9 u1 ~Petechiae:瘀点,瘀斑
+ ~2 }; k) l% C( ?% U; ]6 G* mPfu: plaque forming unit,空斑形成单位! `0 G6 q* c, o4 O+ L! H% [+ ?
PHA:phytahematoagglutinin,植物血凝素
9 g2 s2 z5 J; C7 q) i" ePhlebitis:静脉炎 ( t: f) s. v% W. ~/ g/ [3 J7 n
PHSC:pluripotential hematopoietic stem cell,多能造血干细胞
/ V8 J1 f4 S9 H& A4 N7 {  C0 ~-plasia:(后缀)发展,形成 6 M7 p, l" V' V7 K  C5 r
Plasma:血浆/ \: |: N1 ~* m. ]& O$ g5 v
Plasma cell: 浆细胞
* ^' ^, S3 Q% ~* j* WPlatelet:血小板
5 |6 a: {- _+ w; m, P3 P# ^9 MPLG:plasminogen,纤溶酶原( m7 C) Q7 h$ ^' R8 ?
PLL:prolymphocytic leukemia,幼淋巴细胞白血病
  {: Q; W  Y+ F, P* @PLT:platelet,血小板
+ B+ c2 l- Y% M, M: K8 S/ d. @PLT:primed lymphocyte test,预致敏淋巴细胞试验
4 i' u1 W& O& U, x' n4 ]: _PMN:polymorphonuclear leukocyte,多形核白细胞7 M- L1 @6 w, B6 x' v9 P# M& _
PNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷) K2 s( v" Z: `/ B
PNRE:p53 negative response element,p53阴性反应元件
' J4 t- C8 j; U+ ~  R% A$ x- CPOD:PML oncogenic domain,PML癌基因结构域5 y( o1 r% m, s- k" E% d, @
Polycythemia:红细胞增多症
% o9 u4 R7 w' D* TPositive selection:阳性选择! N. J8 n- W( e8 ~
PPSC: pluripotent hemotopoietic stem cell,全能造血干细胞3 }" m. j& e& C4 _# ^; U. ~( p
Preparative regimen:预处理方案 9 n% O! \7 V4 h, f& i& b
Progenitor:前体,祖先
0 t; s7 R" N) [. ^Prognosis:预后 $ E: G% E/ u% f) N
Prophylactic:adj.预防的;n. 预防性,预防药) n* X4 h3 l- z
Prophylaxis:预防法,预防1 G* S8 F# M: E1 m" w; ^
Protocol:草案,协议,治疗方案
/ L! G+ I" A/ y( ?: hProto-onc: proto-oncogene,原癌基因; {( X% b9 x1 _
PSS:posterior superior spine,髂后上棘# U8 O: k# U: B: a) o! M
PT:prothrombin time,凝血酶原时间# F4 J# c0 T$ s- o+ B+ d
PTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤+ z3 ~! y7 ~1 g" A+ F
PTH:post-transfusion hepatitis, 输血后肝炎2 [5 d3 N2 V, X+ o
Pulmonary:肺的 / V. \( S9 ~4 W0 s8 H
Purging:净化
& z# e: j& z. m1 W3 n  t" [( PPurity:纯度5 I4 e" Q8 k8 E+ ~+ X, n; Y
PV:polycythemia vera,真性红细胞增多症
( w; U/ v$ s  b  ?" n  R8 F! n5 Y6 R9 d2 h+ ~Quality of Life (QOL):生活质量
: y7 N2 i5 H! |' Y3 e  k0 jRA:refractory anemia,难治性贫血 7 L( q: `  _3 ?( v% F
RAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型7 Q* ^9 y+ e* Z
RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型
3 c8 m: r/ U  I+ Q: D; CRAR:retinoic acid receptor,维甲酸受体
, S: z& E% c) n! v% |" L* ?, }2 }RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多
8 S: q; [" u0 |& k+ yRAS:retinoic acid syndrome,维甲酸综合征
, C$ Z# B4 x) m" A( b7 s7 Y" w9 XRB:retinoblastoma,视网膜母细胞瘤
% L' k, D2 O# eRBC: red blood cell,红细胞
- x/ @0 C# z; S0 pReagent:试剂) v# [5 Q% ^3 E( X& U$ A. p! e; Y
Recipient:受者
1 Q- w; E) L6 V3 b+ ZRejection:排斥
2 O7 W9 k3 ]% t0 K* \Relapse:复发 5 m' ?. d8 v  x9 \. U" v; V; v$ S
Remission:缓解 6 r% x8 r/ i1 E' h
Renal:肾脏的,肾的
; {1 [7 d9 y# N' j9 FRFS:replase free survival,无复发生存
) [& P5 y4 ~/ `; C% g) {  y; k+ c. F. K% w1 aRPC:radiation protective competence, 辐射保护能力
: I- I) u) \, x! H& }Regimen-related toxicity (RRT):预处理相关毒性
) f2 j" I: t' i* j" A. b: o& F# h) L, ?RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应
9 Y! l; y( ~" ?/ a! x" [& F" pSBB:sudan black B,苏丹黑B
! L% k8 o  q  ]& u9 {* I8 ~: l7 mSCE:sister chromatial exchange,姐妹染色单体交换' M2 v$ g7 |8 v- t$ m2 H
SCF:stem cell factor,干细胞因子) C$ [; _+ x2 f: z
SCid:severe combined immunodeficiency disease,重症联合免疫缺陷/ V6 v  ~+ `1 N( k7 B
SCL:stem cell leukemia,干细胞白血病
; s- e2 C$ R; qSE:specific estarase,特异性酯酶7 B; A" s3 `- S
Selectin:选择素
3 o' W8 r. E1 R; j: a7 rSense primer:同义引物
; j+ j+ k8 |8 [# \! }& X/ e$ s+ X& eSeparation:(细胞)分选
6 p6 x, z, T) Q* n3 OSepsis:脓血病,败血病 ( k. W4 d- O* V/ w3 N* y
Sequencing测序
% ]5 L' m- ]0 p7 eSF:serum ferritin,血清铁蛋白+ y* c: l8 k' Z$ r4 |
SHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大: |) C$ R  ~2 s+ }. ]0 V8 s
SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法4 Q8 |6 q- X. E2 D: @/ g- Z
SLE:systemic lupus erythematosus,系统性红斑狼疮3 Q" H4 ~& a5 a! a/ B
SLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤" l! b. j9 v5 B* S9 a$ Y! `/ |
Solid tumor:实体瘤
0 }+ y$ c! D  W* M9 HSR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病8 A9 N2 Z' g0 T, p
SRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞) i! l. ]  ]% x( c8 n
SS:Sezary syndrome,Sezary综合征
; q0 [) x  y7 r3 V) n8 GStem cell:干细胞& H% ?* T7 @/ ?
STNI:subtotal nodal irradiation,次全淋巴结照射
) j. O! Z7 ~; O  \) [9 l8 P- TStomatitis:口炎 4 M  y5 d' r4 C& F
Subclavian catheter:锁骨下导管 + d8 w0 |2 [- [) U  R( q
Supernatant:上清) w" Y; \/ S- t
Syn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植 5 F& D& `, ^5 p4 ]# ^
Syngeneic:同基因的) |" l& I, v  x3 ^/ W
TAM:tumor associated macrophage,肿瘤相关巨噬细胞5 |/ g  K7 I3 d# Z+ [- z
t-AML:treatment associated AML,治疗相关的急性髓性白血病
+ v9 E1 H4 e: cTA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病
8 D9 e/ f+ R  ^$ Y% jTAA:tumor associated antigen,肿瘤相关抗原
0 k6 \4 q7 x' Y2 T& ?- lTBGP:total blood granulocyte pool,总血液粒细胞池; |6 o% H. `" [5 F! y3 D2 B# r, n7 [
TBI:total body irradiation,全身照射
* x* \- b) z  N$ P' qTc:time of cell cycle, 细胞周期时间- r; b( g; A2 ]  f' e
TCD:T cell depletion, T细胞去除
$ o; c4 ^" R! [3 u, v. D  cTCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤
1 E  ^" B- q4 ]# u! xTCR:T cell receptor,T细胞受体  k; G" B+ S3 j0 m, q- Q( z- N3 S
TCS:tumor cell survival,肿瘤细胞成活2 W* g7 V) x0 l) M! `' W7 W# h
TEN:total enteral nutrition,完全胃肠内营养
) E; N; f3 W& ], I8 w6 f7 HTF:tissue factor,组织因子
5 ?6 W8 I3 L+ \( l- A" ~* Z& dTF:thymic factor,胸腺因子
6 q0 N; }/ d7 P# M+ D5 O# |TFPI:tissue factor pathway inhibitor,组织因子途径抑制物  v6 n3 l3 r, O+ Q, }! X
TGF:therapeutic gain factor,治疗获得系数
! ~* r: R- T1 F3 ETGF-β:transforming growth factor-β,转化生长因子β
$ ~6 `* O: R: M" AThrombocyte:血小板 0 \3 l. G! O* R
Thrombocytopenia:血小板减少症
- x4 B+ V6 z/ l- mTIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞( W/ p! J4 @+ f3 }$ z5 g- [
TL:testis leukemia睾丸白血病
4 v% n2 D7 ]% B2 E5 H: YTLI:total Lymphoid irradiation,全淋巴照射
0 h6 J  Q6 g# E! I% x1 eThrombotic microangiopathy (TMA):血栓性微血管病
% T3 n/ w) o  ]  w2 OTNF:tumor necrosis factor,肿瘤坏死因子
' r$ X  W- T- o/ ITNI:total nodal irradiation,全淋巴结照射
. N7 |! ?3 }2 O, D1 y4 I+ JTOPO II:topoisomerase II,拓扑易构酶II7 e# j$ d& x: y
Toxin:毒素 * ?. u5 g$ }6 D  f' G
Tpdt:potential doubling time,倍增时间6 K9 e3 K8 D. _0 [) S% e; E/ `
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病6 P5 o# u. u9 f! w
TPN:total parenteral nutrition,全肠道外营养,静脉高营养
& M/ N! C( |4 O& k  U, }" ZTPO:thrombopoietin,促血小板生成素6 K4 z5 K8 s8 l4 q
TPS:treatment planning system,治疗计划系统
& K+ X$ D7 V1 B5 J! Q9 y9 yTranslocation:易位
; r2 O  p8 `. G+ C- ATrauma:创伤 * Q% d' _/ k3 e: d" Y$ K3 _' U
TRM:transplantation related mortality,移植相关死亡率
1 v1 g0 y  E: |TSC:timed-sequential chemotherapy,时相序贯化疗; i# ?" }; S0 L
TSPA:triophosphoramide,噻替派* m/ k/ e; X. y/ V- J
TTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜  q. J3 d) I" P. J$ G0 V, S
Tumor:肿瘤
9 g4 N4 _( N0 f. m) wTumor burden:肿瘤负荷
4 ^+ U% q1 K0 d+ lUCB:umbilical cord blood,脐带血' A* y9 I9 l) `' E: ?
Ultrasound:超声 1 ?6 X) |, d0 j8 o0 o
Umbilical cord:脐带
# [. g" ^7 o! q3 {- VVAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征
, M5 d/ @; p# r+ W2 nVGPR:very good partial remission,非常良好的部分缓解7 O- W% `! i9 _$ W
Viability:活性5 a2 K( A7 P0 x% {/ Q: q8 g
Virus:病毒
' S6 N0 d  K2 m5 RVOD:veno-occlusive disease,静脉阻塞性疾病 6 f1 ]( Y, a0 q# d
v-onc: virus oncogene,病毒癌基因* K6 n, \( i+ u9 t
VPF: vascular permeability factor,血管渗透因子9 o9 t' W4 B+ n' @
VZV:varicella zoster virus,水痘带状疱疹病毒2 ]+ G6 O, t2 [- l* L
WBC:white blood cell,白细胞
. s  P* ^# R* |  r2 s" MWhole blood:全血 ; ~7 I$ w9 p) w  G' J% e
WT:Wilms tumor,肾母细胞瘤4 C+ }% n9 ?. `1 \4 x
Xerostomia:口腔干燥症 8 F! ]+ {& z" X1 i* f3 W9 d+ j8 ~
Yield:产量
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2026-4-8 09:09

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.